文献速递关节外科创伤骨科

半限制型Coonrad/Morrey假体翻修全肘关节置换术:长达21年随访

Revision Total Elbow Arthroplasty with the Semiconstrained Coonrad/Morrey Prosthesis: Follow-up to 21 Years.
PubMed 文献 · J Bone Joint Surg Am · 2021-01-01

结果显示Mayo肘关节性能评分(MEPS)和疼痛评分均显著改善,但并发症发生率高达56%。作者认为该假体可提供良好的临床结果,但需权衡风险收益比。

要点

  • 翻修TEA使用半限制型假体可显著改善MEPS和疼痛,并维持至长期随访。
  • 并发症发生率高(56%),但多数仅需监测,少数需再次手术或假体翻修。
  • 术前应系统评估感染和骨缺损,并与患者讨论风险收益比。

核心结论

  • 使用半限制型假体进行翻修全肘关节置换术可获得良好的临床结果,并能在随访期间维持。
  • 并发症发生率较高,每例翻修术前需评估风险收益比并与患者讨论。

研究设计与样本

  • 平均患者年龄61岁(范围22至76岁),翻修距初次TEA平均7.8年(范围1.6至21年),平均随访11.4年(范围2至21年)。
  • 翻修病因包括肱骨和尺骨无菌性松动(n=14)、尺骨无菌性松动(n=8)、肱骨无菌性松动(n=6)、感染性关节炎(n=4)和不稳定非链接假体(n=2)。
  • 临床和影像学评估包括系统性术前感染检查及骨缺损量化。
  • 证据等级:治疗性IV级。

主要发现

  • 末次随访MEPS:优6例、良18例、可8例、差2例;MEPS从术前42.4±16.1分改善至术后81.8±12分(p < 0.001)。
  • 疼痛评分从术前6.7±1.3分显著改善至术后1.4±1.4分(p < 0.001)。
  • 屈伸弧从术前74°±27°显著增加至术后100°±31°(p = 0.02)。

关键数值与推荐

  • MEPS改善:术前42.4±16.1分至术后81.8±12分(p < 0.001)。
  • 疼痛评分改善:术前6.7±1.3分至术后1.4±1.4分(p < 0.001)。
  • 屈伸弧改善:术前74°±27°至术后100°±31°(p = 0.02)。
  • 并发症:29例次/19例翻修TEA(56%);6例次再次手术;3例次(9%)假体翻修。

临床怎么用

  • 对于全肘关节置换术后无菌性松动、感染性关节炎或不稳定非链接假体失败的患者,可考虑使用半限制型Coonrad/Morrey假体进行翻修。
  • 术前应进行系统性感染检查和骨缺损量化评估。
  • 应向患者说明并发症发生率较高,并共同决策权衡风险收益比。

局限性

  • 回顾性研究,证据等级为治疗性IV级。
  • 无对照组,无法与其他假体或非手术方案比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Revision total elbow arthroplasty (TEA) has increased, especially in young patients with high functional expectations. The objective of this study was to evaluate the long-term results of revision TEA with a single semiconstrained prosthesis. METHODS: Thirty-four revision TEAs were performed with a Coonrad/Morrey prosthesis in 32 patients; 2 patients had bilateral procedures. The mean patient age was 61 years (range, 22 to 76 years), and the revision TEA was performed at a mean time of 7.8 years (range, 1.6 to 21 years) after the primary TEA. Etiologies for revisions were humeral and ulnar aseptic loosening (n = 14), ulnar aseptic loosening (n = 8), humeral aseptic loosening (n = 6), septic arthritis (n = 4), and unstable unlinked prostheses (n = 2). Clinical and radiographic evaluations were performed with systematic preoperative infection workup and quantification of bone loss. The mean follow-up was 11.4 years (range, 2 to 21 years). RESULTS: The Mayo Elbow Performance Score (MEPS) at the last follow-up was excellent in 6 cases, good in 18 cases, fair in 8 cases, and poor in 2 cases, with a mean improvement (and standard deviation) between the preoperative values at 42.4 ± 16.1 points and the postoperative values at 81.8 ± 12 points (p < 0.001). The mean pain scores improved significantly from 6.7 ± 1.3 points preoperatively to 1.4 ± 1.4 points postoperatively (p < 0.001). The flexion-extension arc increased significantly (p = 0.02) from 74° ± 27° preoperatively to 100° ± 31° postoperatively. The total number of complications was 29 in 19 revision TEAs (56%). Twenty of the 29 complications simply required monitoring without surgical intervention. Six repeat surgical procedures were required, and 3 implant revisions (9%) were performed. CONCLUSIONS: Revision TEA with a semiconstrained prosthesis can provide good clinical results that can be maintained during follow-up. The rate of complications is high. Proper evaluation of the risk-benefit ratio is essential for each revision TEA and should be discussed with the patient. LEVEL OF EVIDENCE: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Barret H, Laumonerie P, Delclaux S, et al. Revision Total Elbow Arthroplasty with the Semiconstrained Coonrad/Morrey Prosthesis: Follow-up to 21 Years. J Bone Joint Surg Am. 2021. PMID: 33617163. doi:10.2106/JBJS.20.00889

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。